The gender earnings gap has made headlines recently as political campaigns argue over the issues. But there is another gender gap that gets little attention: the adverse drug reaction risk for women.  Why is the FDA ignoring this problem? From unsafe medical devices to inadequate clinical trials for drugs, the U.S. Food and Drug Administration has turned a blind eye to the unique …